CRL  valuation analysis

Basics
Name: Charles River Laboratories International, Inc
Description: Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $19.19B (342nd)
Sales(TTM): $3.04B (614th)
Earnings(TTM): $376.07M (473rd)

Value
FFER: 2.63*
Actual price: $382.15
* Earnings were reported Aug 04, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Charles River Laboratories International, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Charles River Laboratories International, Inc
"Diagnostics & Research" industry
Book / MarketCap
Charles River Laboratories International, Inc
"Diagnostics & Research" industry
Equity / Assets
Charles River Laboratories International, Inc
"Diagnostics & Research" industry